Pall Corporation has unveiled its first Technical Innovation Centre in Shanghai, China. The centre, which incorporates a filtration validation lab, provides comprehensive filtration technology support for the Chinese biopharmaceuticals industry. According to Pall the centre is the latest strategic addition to Pall’s global capabilities for the Asia-Pacific biopharmaceuticals market.
The facility houses, what Pall claims is, one of the most advanced filtration validation labs in Asia. Certified to ISO9001, ISO14001 and OSHAS 18001 standards, the lab will help Pall customers tomeet the requirements of the new Chinese Good Manufacturing Practices (GMPs) now in development, under which significantly increased regulatory guidelines are expected. The centre is the 11th filtration validation lab in Pall’s worldwide customer support network.